Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cg0070 (7 trials)
gemcitabine (gemzar) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
mitomycin (mutamycin) (1 trial)
n-dodecyl-b-d-maltoside (3 trials)
valrubicin (valstar) (1 trial)
pembrolizumab (keytruda) (1 trial)
nivolumab (opdivo) (1 trial)
Adenoviridae Infections (Phase 3)
Carcinoma (Phase 3)
Carcinoma in Situ (Phase 3)
Carcinoma, Transitional Cell (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Trials (7 total)
Trial APIs (8 total)